Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Sales and Marketing > New Product Development and Launch > Planning and Coordinating Launch > Launch Strategy and Structure

Launch Strategy and Structure Research

Pitfalls to Avoid for a Strong Oncology Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Oncology Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new oncology product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5159)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1862.00   Free Excerpt Available


Patient Factors that Shape a Successful Oncology Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Oncology Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new oncology product's market entry... (ID 5157)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1960.00   Free Excerpt Available


Pitfalls to Avoid for a Strong Metabolic Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Metabolic Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new metabolic product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5141)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1960.00   Free Excerpt Available


Patient Factors that Shape a Successful Metabolic Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Metabolic Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new metabolic product's market entry... (ID 5139)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1862.00   Free Excerpt Available


Payer Factors that Shape a Successful Metabolic Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Metabolic Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how a metabolic product fares in the marketplace... (ID 5138)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1517.00   Free Excerpt Available


Physician Factors that Shape a Successful Metabolic Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Metabolic Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly developing and launching new metabolic products... (ID 5137)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2397.00   Free Excerpt Available


Product Factors that Shape a Successful Metabolic Market Entry: Differentiation, Pricing and Therapy Benefits 
Non-members: Click here to review a complimentary excerpt from "Product Factors that Shape a Successful Metabolic Market Entry: Differentiation, Pricing and Therapy Benefits" STUDY OVERVIEW New metabolic products are constantly entering the biopharmaceutical marketplace; some therapies are immediate successes while others flounder for months... (ID 5136)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2867.00   Free Excerpt Available


Pitfalls to Avoid for a Strong Cardiovascular Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Cardiovascular Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new cardiovascular product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5132)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1960.00   Free Excerpt Available


Patient Factors that Shape a Successful Cardiovascular Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Cardiovascular Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new cardiovascular product's market entry... (ID 5130)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1824.00   Free Excerpt Available


Payer Factors that Shape a Successful Cardiovascular Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Cardiovascular Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how a cardiovascular product fares in the marketplace... (ID 5129)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1785.00   Free Excerpt Available


Physician Factors that Shape a Successful Cardiovascular Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Cardiovascular Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly developing and launching new cardiovascular products... (ID 5128)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2325.00   Free Excerpt Available


Product Factors that Shape a Successful Cardiovascular Market Entry: Differentiation, Pricing and Therapy Benefits 
Non-members: Click here to review a complimentary excerpt from "Product Factors that Shape a Successful Cardiovascular Market Entry: Differentiation, Pricing and Therapy Benefits" STUDY OVERVIEW New cardiovascular products are constantly entering the biopharmaceutical marketplace; some therapies are immediate successes while others flounder for months... (ID 5127)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2500.00   Free Excerpt Available


Pitfalls to Avoid for a Strong Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls 
Non-members: Click here to review a complimentary excerpt from "Pitfalls to Avoid for a Strong Market Entry: Current and Future Risk Levels for Product, Market, Physician, Patient, Payer, Internal and Regulatory Pitfalls" STUDY OVERVIEW For a new product to successfully enter the marketplace, organizations have to be vigilant of the many pitfalls that are part of the launch landscape... (ID 5121)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1947.00   Free Excerpt Available


Resource Allocation and Launch Readiness Factors that Shape a Strong Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions 
Non-members: Click here to review a complimentary excerpt from "Resource Allocation and Launch Readiness Factors that Shape a Strong Market Entry: Stakeholder Allocations, Investment Levels and Resource Levels Across Launch Functions" STUDY OVERVIEW One of the more difficult aspects of planning a new product launch is balancing the different resource and investment allocations that are needed to prepare the marketplace for a new product... (ID 5120)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1888.00   Free Excerpt Available


Patient Factors that Shape a Successful Market Entry: Education and DTC Marketing 
Non-members: Click here to review a complimentary excerpt from "Patient Factors that Shape a Successful Market Entry: Education and DTC Marketing" STUDY OVERVIEW Patients are one of the critical stakeholders in the healthcare marketplace and thus play an important part in a new product's market entry... (ID 5119)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1947.00   Free Excerpt Available


Payer Factors that Shape a Successful Market Entry: Education and Access Insights 
Non-members: Click here to review a complimentary excerpt from "Payer Factors that Shape a Successful Market Entry: Education and Access Insights" STUDY OVERVIEW While many factors affect a pharmaceutical new product launch, it's recognized that payers have become a critical factor in how a product fares in the marketplace... (ID 5118)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $1782.00   Free Excerpt Available


Physician Factors that Shape a Successful Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies 
Non-members: Click here to review a complimentary excerpt from "Physician Factors that Shape a Successful Market Entry: Initial Trial, Thought Leader Engagement, Early Education and New Technologies" STUDY OVERVIEW The pharmaceutical industry is constantly launching new products across multiple therapeutic areas... (ID 5117)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2325.00   Free Excerpt Available


Product Factors that Shape a Successful Market Entry: Differentiation, Pricing and Therapy Benefits 
Non-members: Click here to review a complimentary excerpt from "Product Factors that Shape a Successful Market Entry: Differentiation, Pricing and Therapy Benefits" STUDY OVERVIEW New products are constantly entering the biopharmaceutical marketplace; some products are immediate successes while others flounder for months... (ID 5116)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...
Price: $2500.00   Free Excerpt Available


The Future of Market Research: Achieving a Balance Between Strategic and Tactical 
Non-members: Click here to review a complimentary excerpt from "The Future of Market Research: Achieving a Balance Between Strategic and Tactical" STUDY OVERVIEW Market research (MR) has always been an important function in the pharmaceutical industry, particularly for providing critical insights related to marketing and brand team support... (ID 5113)
Companies Profiled: Adler Life Sciences, LLC, Abbott, Charles River, more ...
Price: $1500.00   Free Excerpt Available


Onglyza Case Study: Lack of Differentiation Mutes a Launch 
Non-members: Click here to review a complimentary excerpt from "Onglyza Case Study: Lack of Differentiation Mutes a Launch" STUDY OVERVIEW Onglyza, a DPP-4 inhibitor class of anti-diabetes drug, was the second DPP-4 to the market behind the blockbuster Januvia... (ID 5109)
Companies Profiled: Bristol-Myers Squibb, AstraZeneca
Price: $2760.00   Free Excerpt Available


Gardasil Case Study: Using Policy as a Springboard for Launch Success 
Non-members: Click here to review a complimentary excerpt from "Gardasil Case Study: Using Policy as a Springboard For Launch Success" STUDY OVERVIEW Gardasil is a vaccine manufactured by Merck that prevents certain diseases caused by the Human Papillomavirus (HPV), including cervical cancer and genital warts... (ID 5108)
Companies Profiled: Merck
Price: $3381.00   Free Excerpt Available



 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.